Health & Nutrition

bg
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

Hims & Hers shares tumble after company misses on margin,...

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts'...

bg
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

Eli Lilly is selling higher-dose vials of Zepbound at a...

Eli Lilly is offering higher-dose vials through its direct-to-consumer website,...

bg
Athenahealth to offer Abridge's AI scribe to its network of thousands of doctors

Athenahealth to offer Abridge's AI scribe to its network...

Athenahealth will offer Abridge's artificial intelligence scribing tool to its network...

bg
How Healthy Are the Impossible Burger and Beyond Meat vs. Beef? 

How Healthy Are the Impossible Burger and Beyond Meat vs....

What happens when you compare the trans fats, saturated fat, sodium, and cholesterol...

bg
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried

Chinese medical devices are in health systems across U.S.,...

Chinese-made medical devices are found in almost every corner of the medical ecosystem,...

bg
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is...

The FDA's decision will threaten the ability of compounding pharmacies to make far...

bg
UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months

UnitedHealth's rough stretch continues, with buyouts, a...

It extends a tumultuous period for UnitedHealth marked by the killing of a top executive,...

bg
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million

Anne Wojcicki has a new offer to take 23andMe private,...

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to...

bg
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers tumble 26% after FDA says semaglutide...

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in...

bg
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it

How the FDA's approval for food additives works, and why...

Experts say that for decades, a legal loophole has allowed companies to include...